Hemrajani Rekha
SEC CIK 1771213 · EDGAR
BoughtSold
Most active insiders at MXCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Swirsky Douglas J | CFO | — | $8,316 |
| 2 | Ahuja Parmeet | CFO | — | — |
| 3 | Johnston John Joseph | Dir | — | — |
| 4 | Masoud Maher | Pres, CEO, Dir | — | — |
| 5 | Hemrajani Rekha | Dir | — | — |
| 6 | Al-Wakeel Yasir B. | Dir | — | — |
| 7 | Brooke William W | Dir | — | — |
| 8 | Collins Cynthia | Dir | — | — |
| 9 | Erck Stanley C | Dir | — | — |
| 10 | BALTHROP PATRICK J | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-22 16:28 | 2026-06-17 | MXCT | MAXCYTE, INC. | Hemrajani Rekha | Dir | A - Grant | $0.00 | +30.4K | 70.3K | +76% | $0 |
| T | 2025-08-27 | 2025-06-25 | MXCT | MAXCYTE, INC. | Hemrajani Rekha | Dir | S - Sale | $2.09 | -10.7K | 39.9K | -21% | -$22.3K |
| D | 2025-06-23 | 2025-06-18 | MXCT | MAXCYTE, INC. | Hemrajani Rekha | Dir | A - Grant | $0.00 | +29.2K | 50.6K | +137% | $0 |
| A | 2025-03-10 | 2024-09-27 | BIOA | BioAge Labs, Inc. | Hemrajani Rekha | Dir | P - Purchase | $18.00 | +3,000 | 3,000 | New | +$54.0K |
| 2024-12-04 | 2024-12-02 | ALXO | ALX ONCOLOGY HOLDINGS INC | Hemrajani Rekha | Dir | P - Purchase | $1.55 | +30.0K | 33.0K | +1,000% | +$46.5K | |
| D | 2024-06-13 | 2024-06-11 | MXCT | MAXCYTE, INC. | Hemrajani Rekha | Dir | A - Grant | $0.00 | +21.4K | 21.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations